Apexian Pharmaceuticals
apexianpharma.comApexian Pharmaceuticals is a clinical stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose work on the APE1/Ref-1 protein has provided unique insight into this important biological target. APE1/REF-1 plays a key role in a variety of inflammatory disorders and tumorigenesis, including cancers of the colon, pancreas, skin, blood, diabetic macular edema, inflammatory bowel disorders and others.
Is this your company?
If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Elevate Ventures network.
Something looks off?
Open jobs at Apexian Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.